• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在突尼斯人群中,次要组织相容性抗原 HA-8 和 PANE1。

Minor histocompatibility antigens HA-8 and PANE1 in the TUNISIAN population.

机构信息

Department of Immunohaematology, National Blood Transfusion Center of Tunis, Tunis, Tunisia.

出版信息

Mol Genet Genomic Med. 2022 Nov;10(11):e2050. doi: 10.1002/mgg3.2050. Epub 2022 Aug 29.

DOI:10.1002/mgg3.2050
PMID:36036171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9651600/
Abstract

BACKGROUND

Minor histocompatibility antigens (mHAgs) are endogenous immunogenic peptides initially identified due to complications detected in several contexts of HLA geno-identical hematopoietic stem cell transplantation (HSCT). In this study, we chose to examine the molecular polymorphism of the mHAgs HA-8 and PANE1 in the Tunisian population.

MATERIAL AND METHODS

This study was conducted on 150 healthy and unrelated individuals. The DNA extraction and Sequence-Specific Primers PCR (PCR-SSP) methods were used for the molecular genotyping of the selected SNPs: PUM3 (rs2173904) and CENPM (rs5758511).

RESULTS

Our results show that, 94% of Tunisians are carriers of the PANE1R allele (immunogenic variant of the PANE1 mHAg) and 68% of Tunisians are carriers of the HA-8R allele (immunogenic variant of the HA-8 mHAg). Furthermore, this study shows that about 5% of the Tunisians are carrier of the PANE1R antigen and its HLA molecule of presentation (the PANE1R/HLA-A0301 combination). However, only 2% of Tunisians are carrier of the HA-8R/HLA-A0201 combination, that is, the HA8 immunogenic variant and its specific HLA molecule of presentation.

CONCLUSION

Our results are close to those reported in Caucasian, Asiatic, and African populations, this may be explained by the historical events experienced by Tunisia for millennia. These results could be used for further clinical and anthropological studies.

摘要

背景

次要组织相容性抗原(mHAgs)是最初因在几个 HLA 基因相同的造血干细胞移植(HSCT)背景下检测到的并发症而被识别的内源性免疫原性肽。在这项研究中,我们选择研究 mHAgs HA-8 和 PANE1 在突尼斯人群中的分子多态性。

材料和方法

这项研究在 150 名健康且无亲缘关系的个体中进行。使用 DNA 提取和序列特异性引物聚合酶链反应(PCR-SSP)方法对所选 SNP 进行分子基因分型:PUM3(rs2173904)和 CENPM(rs5758511)。

结果

我们的结果表明,94%的突尼斯人是 PANE1R 等位基因(PANE1 mHAg 的免疫变体)的携带者,68%的突尼斯人是 HA-8R 等位基因(HA-8 mHAg 的免疫变体)的携带者。此外,这项研究表明,约 5%的突尼斯人是 PANE1R 抗原及其 HLA 呈递分子(PANE1R/HLA-A0301 组合)的携带者。然而,只有 2%的突尼斯人是 HA-8R/HLA-A0201 组合的携带者,即 HA8 免疫变体及其特定的 HLA 呈递分子。

结论

我们的结果与高加索人、亚洲人和非洲人的报告结果相似,这可能是由于突尼斯数千年来经历的历史事件造成的。这些结果可用于进一步的临床和人类学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9651600/bd7649e3b8c1/MGG3-10-e2050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9651600/bd7649e3b8c1/MGG3-10-e2050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9651600/bd7649e3b8c1/MGG3-10-e2050-g001.jpg

相似文献

1
Minor histocompatibility antigens HA-8 and PANE1 in the TUNISIAN population.在突尼斯人群中,次要组织相容性抗原 HA-8 和 PANE1。
Mol Genet Genomic Med. 2022 Nov;10(11):e2050. doi: 10.1002/mgg3.2050. Epub 2022 Aug 29.
2
HA-1 and HA-2 minor histocompatibility antigens in Tunisians.突尼斯人中的HA-1和HA-2次要组织相容性抗原
Tissue Antigens. 2010 Jun;75(6):720-3. doi: 10.1111/j.1399-0039.2010.01444.x. Epub 2010 Jan 28.
3
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.多中心分析表明,在 HLA 匹配的相关和无关造血干细胞移植后,次要组织相容性抗原对移植物抗宿主病和移植物抗肿瘤效应具有显著的临床影响。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.
4
Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?次要组织相容性抗原 HA-1 不匹配是否会影响突尼斯造血干细胞移植受者移植物抗宿主病的发生?
Clinics (Sao Paulo). 2010;65(11):1099-103. doi: 10.1590/s1807-59322010001100007.
5
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.PANE1基因编码一种新型人类次要组织相容性抗原,该抗原在B淋巴细胞和B细胞慢性淋巴细胞白血病中选择性表达。
Blood. 2006 May 1;107(9):3779-86. doi: 10.1182/blood-2005-08-3501. Epub 2006 Jan 3.
6
Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT.韩国人群中次要组织相容性抗原的分布及无关造血干细胞移植中的差异
Bone Marrow Transplant. 2007 Oct;40(8):723-8. doi: 10.1038/sj.bmt.1705808. Epub 2007 Aug 13.
7
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR.通过等位基因特异性PCR对次要组织相容性抗原HA-1位点进行基因组鉴定。
Tissue Antigens. 1998 Oct;52(4):312-7. doi: 10.1111/j.1399-0039.1998.tb03053.x.
8
Role of minor histocompatibility antigens in renal transplantation.次要组织相容性抗原在肾移植中的作用。
Am J Transplant. 2008 Jan;8(1):95-102. doi: 10.1111/j.1600-6143.2007.02042.x. Epub 2007 Dec 18.
9
Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.供者 CTLA-4 等位基因和单倍型对接受 HLA 相合同胞造血干细胞移植的突尼斯患者移植物抗宿主病发生的影响。
Hum Immunol. 2011 Feb;72(2):139-43. doi: 10.1016/j.humimm.2010.11.008. Epub 2010 Nov 13.
10
[Frequency of minor histocompatibility antigens among Chilean blood donors].[智利献血者中次要组织相容性抗原的频率]
Rev Med Chil. 2012 May;140(5):555-60. doi: 10.4067/S0034-98872012000500001.

本文引用的文献

1
Trophoblast antigens, fetal blood cell antigens, and the paradox of fetomaternal tolerance.滋养层抗原、胎儿血细胞抗原与胎母免疫耐受的悖论。
J Exp Med. 2022 May 2;219(5). doi: 10.1084/jem.20211515. Epub 2022 Apr 13.
2
Modeling acute graft-versus-host disease (aGVHD) in murine bone marrow transplantation (BMT) models with MHC disparity.利用 MHC 差异建立小鼠骨髓移植(BMT)模型模拟急性移植物抗宿主病(aGVHD)。
Methods Cell Biol. 2022;168:19-39. doi: 10.1016/bs.mcb.2021.12.007. Epub 2022 Jan 10.
3
Antibody Responses to Minor Histocompatibility Antigens After Solid Organ Transplantation.
实体器官移植后对次要组织相容性抗原的抗体反应。
Transplantation. 2022 Apr 1;106(4):749-753. doi: 10.1097/TP.0000000000003969.
4
Biomarkers of graft--host disease: Understanding and applications for the future.移植物抗宿主病的生物标志物:对未来的理解与应用
World J Transplant. 2021 Aug 18;11(8):335-343. doi: 10.5500/wjt.v11.i8.335.
5
Minor Histocompatibility Antigen-Specific T Cells.次要组织相容性抗原特异性T细胞
Front Pediatr. 2020 Jun 3;8:284. doi: 10.3389/fped.2020.00284. eCollection 2020.
6
Which factors influence the development of GVHD in HLA-matched or mismatched transplants?哪些因素会影响HLA匹配或不匹配移植中移植物抗宿主病的发生?
Best Pract Res Clin Haematol. 2017 Dec;30(4):333-335. doi: 10.1016/j.beha.2017.09.003. Epub 2017 Sep 22.
7
Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.主要组织相容性复合体变异在造血细胞移植后移植物抗宿主病中的作用。
F1000Res. 2017 May 3;6:617. doi: 10.12688/f1000research.10990.1. eCollection 2017.
8
Pathophysiology of GvHD and Other HSCT-Related Major Complications.移植物抗宿主病及其他造血干细胞移植相关主要并发症的病理生理学
Front Immunol. 2017 Mar 20;8:79. doi: 10.3389/fimmu.2017.00079. eCollection 2017.
9
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.全基因组次要组织相容性匹配与移植物抗宿主病风险的关系
Blood. 2017 Feb 9;129(6):791-798. doi: 10.1182/blood-2016-09-737700. Epub 2016 Nov 21.
10
The Orientalisation of North Africa: New hints from the study of autosomal STRs in an Arab population.北非的东方化:来自阿拉伯人群常染色体短串联重复序列研究的新线索。
Ann Hum Biol. 2017 Mar;44(2):180-190. doi: 10.1080/03014460.2016.1205135. Epub 2016 Jul 17.